InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（13 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
13
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Bensen Daniel, 管理人员. Director active across 1 company, notably Tyra Biosciences, Inc.. In total, 24 disclosures have been published. Split: 0 buy · 13 sells. Total volume traded: €1.8m. Activity tracked since 21 March 2023. The latest transaction was filed on 12 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bensen Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
2,128 股@ US$31.50183.1% 占其流量Common StockSEC:0001193125-26-051534:0
1,017 股@ US$29.08084.7% 占其流量Common StockSEC:0001193125-26-016651:1
6,983 股@ US$28.44231.4% 占其流量Common StockSEC:0001193125-26-016651:0
8,000 股@ US$22.64498.8% 占其流量Common StockSEC:0001193125-25-320941:0
75,633 股@ US$16.072765.2% 占其流量Common StockSEC:0001193125-25-288529:0
1,111 股@ US$16.00362.7% 占其流量Common StockSEC:0001193125-25-284935:0
200 股@ US$20.000.7% 占其流量Common StockSEC:0000950170-24-071500:0
200 股@ US$20.000.7% 占其流量Common StockSEC:0000950170-24-030932:0
1,733 股@ US$20.0925.9% 占其流量Common StockSEC:0000950170-24-028807:0
2,900 股@ US$20.03869.9% 占其流量Common StockSEC:0000950170-24-026365:0
745 股@ US$20.002.5% 占其流量Common StockSEC:0000950170-24-023406:0
1,501 股@ US$20.005.1% 占其流量Common StockSEC:0000950170-24-015559:0
9,587 股@ US$18.093929.7% 占其流量Common StockSEC:0000950170-24-013474:0
25,393 股@ US$0.612.6% 占其流量Common StockSEC:0000950170-24-011880:0
207 股@ US$0.610.0% 占其流量Common StockSEC:0001209191-23-043165:0
500 股@ US$0.610.0% 占其流量Common StockSEC:0001209191-23-042495:0
1,202 股@ US$0.610.1% 占其流量Common StockSEC:0001209191-23-042114:0
17,281 股@ US$0.611.8% 占其流量Common StockSEC:0001209191-23-040654:0
17,232 股@ US$0.611.8% 占其流量Common StockSEC:0001209191-23-040105:0
5,628 股@ US$0.610.6% 占其流量Common StockSEC:0001209191-23-037611:0
2,000 股@ US$0.610.2% 占其流量Common StockSEC:0001209191-23-022432:0
8,048 股@ US$0.610.8% 占其流量Common StockSEC:0001209191-23-021564:0
14,100 股@ US$0.611.5% 占其流量Common StockSEC:0001209191-23-020846:0
8,501 股Common StockSEC:0000899243-21-036432:0
24 条申报中的 24 条
About Bensen Daniel
Bensen Daniel is Dirigeant and Chief Discovery Officer at Tyra Biosciences, Inc. (XNAS). He has 24 filings in total, and in the sampled recent filings from 2021-09-17 to 2026-02-13, the modal transaction nature is Cession, with sum_sell_eur at 1767189 and sum_buy_eur at 0.
